On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdayApr 17, 2024 2:46 pm

QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Announces Expansion of Investigative Pipeline

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. The company today announced the expansion of its pipeline into metabolic and related disorders including weight loss and liver health. FSD Pharma has initiated investigations into certain ingredients and combinations of ingredients that show promise in improving liver health, reducing metabolic disease and reducing visceral fat. The company is leading these efforts to potentially create a new exciting product line in addition to unbuzzd(TM). To view the full press release, visit https://ibn.fm/mpMNa About FSD Pharma Inc. FSD is…

Continue Reading

TuesdayApr 16, 2024 3:50 pm

QualityStocksNewsBreaks – Podfest Expo Names IBN as Official Media Partner for Premier Podfest Master Class

Podfest Expo and its parent company, Cutting Edge Events, has selected InvestorBrandNetwork (“IBN”), a pioneer in corporate communications and content distribution, to be the official media partner for its upcoming Podfest Master Class. The virtual master class is scheduled for April 19, 22–24, 2024. This unique event is designed to be premier online summit and foremost platform for world-class education and quality content creation exclusively for the global podcasting community. This year’s event is focused on AI and creator tools, with an agenda featuring unparalleled educational experiences, technological insights, and top-tier content creation and dissemination; the event also includes invaluable networking…

Continue Reading

TuesdayApr 16, 2024 3:46 pm

QualityStocksNewsBreaks – Vape South America Medellín 2024 to Showcase Innovation in Alternative Products Supply Chain

Alternative Products Expo has announced the return of the world’s premier counterculture industry event to Medellín, Colombia. Another first-class production of ZJ Events, Vape South America Medellín 2024 is slated to take place at the Centro de Convenciones Plaza Mayor in Medellín from May 18-19, 2024. Strategically located with a welcoming atmosphere and great climate, the Vape South America Medellín 2024 has become a prime gateway between the U.S. and South American markets and offers a unique opportunity to establish connections with buyers and distributors from around the globe. “Vape South America Medellín 2024 is a globally renowned platform in…

Continue Reading

TuesdayApr 16, 2024 3:39 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Approval to Commence Human Pilot Study Evaluating GLP-1, DehydraTECH

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received approval to begin a new human pilot study. The approval, which was granted by an independent third-party ethics review board, enables Lexaria to move forward with its plan to conduct a GLP-1 study investigating GLP-1 drugs and DehydraTECH(TM). According to the announcement, subject recruitment will begin immediately with the first dosing expected within the next month; the company plans to complete the study this summer. The study will be comprised of two study arms and will include up to nine healthy volunteers. The study is designed to…

Continue Reading

TuesdayApr 16, 2024 1:33 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on additional preclinical data for INM-089, a proprietary small molecule compound acting as a preferential signaling ligand of cannabinoid receptor 1 (“CB1”) and cannabinoid receptor 2 (“CB2”). The reported data continues to demonstrate positive pharmacological effects in the treatment of dry age-related macular degeneration (“AMD”). According to the announcement, in vivo preclinical studies in AMD disease models show that INM-089 delivers improved retinal pigment epithelium integrity, neuroprotection and photoreceptor improvement. Earlier results showed that INM-089 also preserved retinal function…

Continue Reading

TuesdayApr 16, 2024 1:07 pm

QualityStocksNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Reports on Results of Drill Program at Albert Lake Project

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), an exploration company targeting magmatic nickel sulphide discoveries to support the rapidly growing global electric vehicle market, is reporting on the results of the Q1 drill program at the company's wholly owned Albert Lake Project. Key points from the program include that six drillholes have been drilled at the project, totaling 1,386 meters, with Drillhole AL24077 intersecting 0.42% nickel (“Ni”) over an intersection of 2.01 meters; the nickel mineralization is hosted in orthopyroxenite, which is part of the host rock assemblage recognized at the nearby high-grade Ni-Cu+PGE Rottenstone deposit; and the AL24077 nickel…

Continue Reading

TuesdayApr 16, 2024 12:36 pm

QualityStocksNewsBreaks – SUIC Worldwide Holdings Ltd. (SUIC), I.Hart Group Ink Franchise Authorizations with MONGA Fried Chicken

SUIC Worldwide Holdings (OTC: SUIC), a publicly traded technology company, and its I.Hart Group Taiwan Ltd. have signed a franchise authorization with MONGA(C) Fried Chicken in Japan and in China’s Shandong Province. This is a key step as SUIC and I.Hart evaluate additional high-growth markets in Asia, which offers the largest long-term growth opportunity in the global food industry. According to the announcement, Shandong plans to open 10 stores in the first year and 300 stores within the following five years; the franchise authorizations also increase the companies' presence across 11 countries. With these additions, SUIC and I.Hart Group will have…

Continue Reading

MondayApr 15, 2024 1:24 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Represents Opportunity to Provide Solution for GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biopharmaceutical company advancing its lead drug candidate, Berubicin, along the pathway to potential regulatory approval and commercialization, recently appointed Amy Mahery to its board of directors. “A biotech commercialization leader, Ms. Mahery has built an illustrious career that spans more than 20 years. During this period, she has gained commercial expertise working with small and large companies in common and rare conditions, as well as across several therapeutic areas… Ms. Mahery lauded CNS Pharmaceuticals and its efforts to fill gaps in areas with high unmet medical needs, such as glioblastoma multiforme (‘GBM’) treatment, saying,…

Continue Reading

MondayApr 15, 2024 12:07 pm

QualityStocksNewsBreaks – SOBR Safe Inc.’s (NASDAQ: SOBR) SOBRcheck(TM) Delivers Superior Performance vs. Traditional Breathalyzers

SOBR Safe (NASDAQ: SOBR) (“SOBRsafe”), a disruptive company leveraging advanced alcohol detection approaches and technologies, recently published three case studies that empirically demonstrate the performance of its alcohol screening technology, SOBRcheck(TM), based on customer data, experiences and results. “A stationary identification and alcohol screening/monitoring technology launched in 2021, SOBRcheck detects and instantaneously reports the presence of alcohol emitted through the pores of a fingertip. It is equipped with a biometric identifier that automatically confirms the user’s identity and hardcodes this identification information, as well as the date and time of the screening, into the automatically generated reports, thus boosting reliability,”…

Continue Reading

FridayApr 12, 2024 3:30 pm

QualityStocksNewsBreaks – Zoned Properties Inc. (ZDPY) Continues to Align with Evolving Cannabis Market

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, is focusing on seizing direct-to-consumer real estate opportunities in the rapidly growing and regulated cannabis market. This is amid changing regulations and attitudes towards cannabis use, which are transforming the industry. “Cannabis businesses are expanding significantly as regulations evolve, leading to an increased demand for specialized, direct-to-consumer properties that include dispensaries, manufacturing or processing centers, and distribution hubs. Real estate investors are capitalizing on this demand by acquiring properties for rental income generation while potentially realizing significant property value appreciation as the industry grows,” a…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered